Wellcome

Bioactive Natural products in Drug Discovery (Record no. 552741)

MARC details
000 -LEADER
fixed length control field 06183nam a22005895i 4500
001 -
control field 978-981-15-1394-7
003 -
control field DE-He213
005 -
control field 20211012190905.0
007 -
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200430s2020 si | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789811513947
-- 978-981-15-1394-7
024 7# -
-- 10.1007/978-981-15-1394-7
-- doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
-- QR46
072 #7 -
-- MMFM
-- bicssc
-- MED052000
-- bisacsh
-- MKFM
-- thema
082 04 -
Classification number 616.9041
-- 23
245 10 - TITLE STATEMENT
Title Bioactive Natural products in Drug Discovery
Statement of responsibility, etc edited by Joginder Singh, Vineet Meshram, Mahiti Gupta.
250 ## - EDITION STATEMENT
Edition statement 1st ed. 2020.
300 ## - PHYSICAL DESCRIPTION
Extent XII, 733 p. 96 illus., 32 illus. in color.
Other physical details online resource.
505 0# -
Formatted contents note Chapter 1. The Artemisia genus: Panacea to Several Maladies -- Chapter 2. Bacopa monnieri: the Neuroprotective Elixir from the East: Phytochemistry, Pharmacology and Biotechnological Improvement -- Chapter 3. Current knowledge of Cinnamomum species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies -- Chapter 4. Swertia spp. : A potential source of high-value bioactive components, Pharmacology and Analytical techniques -- Chapter 5. The Genus Calophyllum: Review of Ethnomedicinal uses, Phytochemistry and Pharmacology -- Chapter 6. Plant Derived Quinones as a Source of Antibacterial and Anticancer Agents -- Chapter 7. Drugging protein-protein interaction interface with natural products: a computational approach -- Chapter 8. CQDs derived from natural sources: Excellent bio-imaging agents -- Chapter 9. Microbial Natural products: Recent insights into novel applications -- Chapter 10. Bioactive peptides and carbohydrates from natural products: a source of functional foods and nutraceuticals -- Chapter 11. Metabolites of fluorescent pseudomonads and their antimicrobial and anticancer potentials -- Chapter 12. Medicinal fungi: A natural source of pharmacologically important metabolites -- Chapter 13. Ganoderma: A propitious medicinal poroid mushroom -- Chapter 14. Pharmaceutically important metabolites from marine Fungi -- Chapter 15. Endophytic fungi: a trove of novel bioactive compounds -- Chapter 16. Novel Products from Microalgae -- Chapter 17. Lactic Acid Production and its Application in pharmaceuticals -- Chapter 18. Microbial Clot Busters: an Overview of Source, Production, Properties and Fibrinolytic Activity -- Chapter 19. Carbohydrate biopolymers: Diversity, applications and challenges -- Chapter 20. Biotechnological aspects of nanoparticles driven from natural products for drug delivery system and other applications -- Chapter 21. Methods and Techniques for the Chemical Profiling and Quality Control of Natural Products and Natural Product Driven Drugs -- Chapter 22. Characterization of Bioactive Secondary Metabolites of Fungal Endophytes -- Chapter 23. Modulation of Cellular Protein Quality Control Pathways Using Small Natural Molecules -- Chapter 24. Elaborating on the potential for mushroom-based products market expansion: Consumers' attitudes and purchasing intentions -- Chapter 25. The Role of Algae in Nutraceutical and Pharmaceutical Production -- Chapter 26. Microbial interventions to induce secondary metabolites biosynthesis in medicinal and aromatic plants -- Chapter 27. Peptaibols: Antimicrobial peptides from Fungi.
650 #0 -
Topical term or geographic name as entry element Medical microbiology.
Topical term or geographic name as entry element Microbiology.
Topical term or geographic name as entry element Plant genetics.
Topical term or geographic name as entry element Pharmacology.
Topical term or geographic name as entry element Microbial genetics.
Topical term or geographic name as entry element Microbial genomics.
Topical term or geographic name as entry element Medical Microbiology.
Topical term or geographic name as entry element Applied Microbiology.
Topical term or geographic name as entry element Plant Genetics and Genomics.
Topical term or geographic name as entry element Pharmacology/Toxicology.
Topical term or geographic name as entry element Microbial Genetics and Genomics.
700 1# -
Personal name Singh, Joginder.
Relator term editor.
Personal name Meshram, Vineet.
Relator term editor.
Personal name Gupta, Mahiti.
Relator term editor.
710 2# -
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
856 40 -
Uniform Resource Identifier https://doi.org/10.1007/978-981-15-1394-7
245 10 - TITLE STATEMENT
-- [electronic resource] /
264 #1 -
-- Singapore :
-- Springer Singapore :
-- Imprint: Springer,
-- 2020.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
520 ## -
-- This book highlights different natural products that are derived from the plants and microbes that have shown potential as the lead compounds against infectious diseases and cancer. Natural products represent an untapped source of strikingly diverse chemotypes with novel mechanisms of action and the potential to serve as anticancer and anti-infective agents. The book discusses a range of biotechnologically valuable bioactive compounds and secondary metabolites that have been derived from plant and microorganisms from various ecological niches. It also reviews the latest developments in the field of genomics, bioinformatics and industrial fermentation for harnessing the microbial products for commercial applications. In turn, the book's closing section reviews important biotechnological applications of various natural products. Combining the expertise of specialists in this field, the book's goal is to promote the further investigation of natural sources for the development of standardized, safe and effective therapies.
-- https://scigraph.springernature.com/ontologies/product-market-codes/B16003
-- https://scigraph.springernature.com/ontologies/product-market-codes/C12010
-- https://scigraph.springernature.com/ontologies/product-market-codes/L32020
-- https://scigraph.springernature.com/ontologies/product-market-codes/B21007
-- https://scigraph.springernature.com/ontologies/product-market-codes/L32010
700 1# -
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
773 0# -
-- Springer Nature eBook
776 08 -
-- Printed edition:
-- 9789811513930
-- Printed edition:
-- 9789811513954
-- Printed edition:
-- 9789811513961
912 ## -
-- ZDB-2-SBL
-- ZDB-2-SXB
950 ## -
-- Biomedical and Life Sciences (SpringerNature-11642)
-- Biomedical and Life Sciences (R0) (SpringerNature-43708)
Holdings
Withdrawn status Lost status Damaged status Home library Current library Date acquired Total Checkouts Date last seen Koha item type
      Mysore University Main Library Mysore University Main Library 12/10/2021   12/10/2021 Ebooks

No. of hits (from 9th Mar 12) :

Powered by Koha